|
Apr 30
|
Press Release: Annual General Meeting of April 30, 2024
|
|
Apr 26
|
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
|
|
Apr 25
|
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
|
|
Apr 25
|
Sanofi (SNY) Q1 2024 Earnings Call Transcript
|
|
Apr 25
|
20 Fastest Growing Health Tech Companies in the World
|
|
Apr 25
|
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
|
|
Apr 25
|
Sanofi Sales, Profit Beat Expectations
|
|
Apr 25
|
UPDATE 2-Sanofi profit slips on generic competition and currency effects
|
|
Apr 25
|
Sanofi profit slips on generic competition and currency effects
|
|
Apr 25
|
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
|
|
Apr 24
|
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
|
|
Apr 23
|
Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff
|
|
Apr 23
|
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
|
|
Apr 23
|
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
|
|
Apr 22
|
Market Chatter: Sanofi to Pay More Than $100 Million to Settle 4,000 Suits Alleging Zantac Causes Cancer
|
|
Apr 18
|
Sanofi to overhaul US operations of vaccines, cut jobs
|
|
Apr 17
|
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
|
|
Apr 12
|
Sanofi: Information concerning the total number of voting rights and shares - March 2024
|
|
Apr 8
|
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents
|
|
Apr 7
|
10 Best Weight Loss Drug Stocks to Buy Now
|